Guided Therapeutics (GTHP) Inventory (2011 - 2025)
Guided Therapeutics (GTHP) reported Inventory of $448000.0 for Q4 2025, down 29.23% on a YoY basis from $633000.0 in Q4 2024, and down 23.16% sequentially from $583000.0 in Q3 2025.
Guided Therapeutics (GTHP) Inventory (2011 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 15 years of Inventory data on file, last reported at $448000.0 in Q4 2025.
- For the quarter ending Q4 2025, Inventory fell 29.23% year-over-year to $448000.0; the trailing twelve-month figure through Dec 2025 stood at $448000.0 (down 29.23% YoY), and the FY2025 full-year result was $448000.0, down 29.23% from the prior year.
- Inventory retreated to $448000.0 in Q4 2025, from $583000.0 in the prior quarter.
- In the past five years, Inventory ranged from a high of $648000.0 in Q3 2023 to a low of $448000.0 in Q4 2025.
- A 5-year average of $595550.0 and a median of $595500.0 in 2022 frame the typical range for Inventory.
- Across the five-year window, Inventory soared 1137.25% in 2021 and slipped 29.23% in 2025, its largest moves.
- Tracing GTHP's Inventory over 5 years: stood at $571000.0 in 2021, then slipped by 4.03% to $548000.0 in 2022, then gained by 15.33% to $632000.0 in 2023, then grew by 0.16% to $633000.0 in 2024, then fell by 29.23% to $448000.0 in 2025.
- Business Quant data shows GTHP's Inventory at $448000.0 in Q4 2025, $583000.0 in Q3 2025, and $595000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.99 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 5.42 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 5.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.12 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.12 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 693.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.64 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.35 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 2.12 Bn |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | 448,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 448,000.00 |
| Sep 30, 2025 | 583,000.00 |
| Jun 30, 2025 | 595,000.00 |
| Mar 31, 2025 | 633,000.00 |
| Dec 31, 2024 | 633,000.00 |
| Sep 30, 2024 | 636,000.00 |
| Jun 30, 2024 | 632,000.00 |
| Mar 31, 2024 | 632,000.00 |
| Dec 31, 2023 | 632,000.00 |
| Sep 30, 2023 | 648,000.00 |
| Jun 30, 2023 | 573,000.00 |
| Mar 31, 2023 | 585,000.00 |
| Dec 31, 2022 | 548,000.00 |
| Sep 30, 2022 | 596,000.00 |
| Jun 30, 2022 | 569,000.00 |
| Mar 31, 2022 | 570,000.00 |
| Dec 31, 2021 | 571,000.00 |
| Sep 30, 2021 | 590,000.00 |
| Jun 30, 2021 | 631,000.00 |
| Mar 31, 2021 | 606,000.00 |